Published in Neuropsychopharmacology on September 12, 2012
Chronic cocaine-regulated epigenomic changes in mouse nucleus accumbens. Genome Biol (2014) 1.88
Neural and psychological mechanisms underlying compulsive drug seeking habits and drug memories--indications for novel treatments of addiction. Eur J Neurosci (2014) 1.18
Rodent models for compulsive alcohol intake. Alcohol (2014) 0.93
Epigenetics, microRNA, and addiction. Dialogues Clin Neurosci (2014) 0.85
Regulation of Pancreatic Beta Cell Stimulus-Secretion Coupling by microRNAs. Genes (Basel) (2014) 0.85
How Preclinical Models Evolved to Resemble the Diagnostic Criteria of Drug Addiction. Biol Psychiatry (2015) 0.84
Epigenetic mechanisms in psychiatry. Neuropsychopharmacology (2013) 0.83
Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute simian immunodeficiency virus infection of rhesus macaques. J Virol (2014) 0.83
Synaptic adaptations by alcohol and drugs of abuse: changes in microRNA expression and mRNA regulation. Front Mol Neurosci (2014) 0.81
BDNF rescues BAF53b-dependent synaptic plasticity and cocaine-associated memory in the nucleus accumbens. Nat Commun (2016) 0.77
Modelling depression in animals: at the interface of reward and stress pathways. Psychopharmacology (Berl) (2017) 0.76
MicroRNAs Modulate Interactions between Stress and Risk for Cocaine Addiction. Front Cell Neurosci (2016) 0.75
MicroRNAs and Drinking: Association between the Pre-miR-27a rs895819 Polymorphism and Alcohol Consumption in a Mediterranean Population. Int J Mol Sci (2016) 0.75
The snoRNA MBII-52 regulates cocaine-induced conditioned place preference and locomotion in mice. PLoS One (2014) 0.75
Post-transcriptional regulation of dopamine D1 receptor expression in caudate-putamen of cocaine-sensitized mice. Eur J Neurosci (2015) 0.75
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Human MicroRNA targets. PLoS Biol (2004) 34.51
A mammalian microRNA expression atlas based on small RNA library sequencing. Cell (2007) 34.03
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet (1999) 22.84
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (1998) 18.36
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci (2005) 16.18
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A (1988) 11.96
Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell (1989) 11.41
A brain-specific microRNA regulates dendritic spine development. Nature (2006) 10.18
MeCP2, a key contributor to neurological disease, activates and represses transcription. Science (2008) 10.11
Function and regulation of CREB family transcription factors in the nervous system. Neuron (2002) 7.99
CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem (1999) 7.94
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature (1996) 7.26
A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci U S A (2005) 6.61
Enhancement of cellular memory by reducing stochastic transitions. Nature (2005) 6.01
MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol Cell (2007) 5.67
Transition from moderate to excessive drug intake: change in hedonic set point. Science (1998) 5.66
Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning. Eur J Neurosci (2004) 5.62
Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science (2010) 5.48
Evidence for addiction-like behavior in the rat. Science (2004) 5.19
Structure and nucleic-acid binding of the Drosophila Argonaute 2 PAZ domain. Nature (2003) 4.92
The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell (2004) 4.91
The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron (2006) 4.74
Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat Neurosci (2003) 4.60
A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature (2008) 4.43
Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature (1999) 4.29
Regulation of cocaine reward by CREB. Science (1998) 4.07
Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature (1997) 4.01
An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc Natl Acad Sci U S A (2008) 3.98
Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science (2010) 3.97
Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron (2011) 3.93
Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A (2004) 3.87
Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet (2005) 3.87
Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat Neurosci (2007) 3.81
Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens. Proc Natl Acad Sci U S A (2006) 3.68
Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci (2008) 3.50
Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature (1999) 3.50
Involvement of the dorsal striatum in cue-controlled cocaine seeking. J Neurosci (2005) 3.44
Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci (2007) 3.44
Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci (2003) 3.30
Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature (2001) 3.09
Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J Neurosci (2000) 3.09
Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron (2008) 3.01
MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci (2010) 3.00
Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins. Neuron (2009) 2.97
Amphetamine abuse. Pattern and effects of high doses taken intravenously. JAMA (1967) 2.93
Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nat Neurosci (2005) 2.90
Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat Neurosci (2002) 2.83
A range of research-based pharmacotherapies for addiction. Science (1997) 2.75
Cocaine-reinforced behavior in rats: effects of reinforcement magnitude and fixed-ratio size. J Pharmacol Exp Ther (1968) 2.68
Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci U S A (1995) 2.66
DeltaFosB: a sustained molecular switch for addiction. Proc Natl Acad Sci U S A (2001) 2.64
Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron (1994) 2.61
Striatal microRNA controls cocaine intake through CREB signalling. Nature (2010) 2.56
DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science (1998) 2.53
Differential control over cocaine-seeking behavior by nucleus accumbens core and shell. Nat Neurosci (2004) 2.52
A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci (2004) 2.47
Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci (1999) 2.36
Shift from goal-directed to habitual cocaine seeking after prolonged experience in rats. J Neurosci (2010) 2.33
Pharmacotherapy of addictions. Nat Rev Drug Discov (2002) 2.31
Differential involvement of the core and shell subregions of the nucleus accumbens in conditioned cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) (2004) 2.29
CREB-binding protein controls response to cocaine by acetylating histones at the fosB promoter in the mouse striatum. Proc Natl Acad Sci U S A (2005) 2.28
Nuclear factor kappa B signaling regulates neuronal morphology and cocaine reward. J Neurosci (2009) 2.25
Escalation of methamphetamine self-administration in rats: a dose-effect function. Psychopharmacology (Berl) (2006) 2.24
Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J Neurosci (1997) 2.17
Striatal cell type-specific overexpression of DeltaFosB enhances incentive for cocaine. J Neurosci (2003) 2.16
Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol Pharmacol (2006) 2.13
A phosphatase cascade by which rewarding stimuli control nucleosomal response. Nature (2008) 2.10
Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology (2000) 2.04
MicroRNAs in neuronal function and dysfunction. Trends Neurosci (2012) 1.94
A role for repressive histone methylation in cocaine-induced vulnerability to stress. Neuron (2011) 1.92
Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats. Science (1962) 1.90
The Creb1 coactivator Crtc1 is required for energy balance and fertility. Nat Med (2008) 1.87
Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function. Psychopharmacology (Berl) (2005) 1.82
Nicotine self-administration in rats. Psychopharmacology (Berl) (1995) 1.72
microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Mol Cell Neurosci (2009) 1.71
Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J Neurosci (1998) 1.70
Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc Natl Acad Sci U S A (2009) 1.67
Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs. Nat Neurosci (2008) 1.63
Involvement of the olfactory tubercle in cocaine reward: intracranial self-administration studies. J Neurosci (2003) 1.61
Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo. J Neurosci (1997) 1.59
Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res (1995) 1.59
Toxicity associated with long-term intravenous heroin and cocaine self-administration in the rat. JAMA (1985) 1.57
Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron (1995) 1.56
Tropomyosin-related kinase B in the mesolimbic dopamine system: region-specific effects on cocaine reward. Biol Psychiatry (2008) 1.55
TORC1 is a calcium- and cAMP-sensitive coincidence detector involved in hippocampal long-term synaptic plasticity. Proc Natl Acad Sci U S A (2007) 1.52
Brain reward systems and compulsive drug use. Trends Pharmacol Sci (2007) 1.42
Effects of dose and session duration on cocaine self-administration in rats. J Pharmacol Exp Ther (2007) 1.42
Argonaute 2 in dopamine 2 receptor-expressing neurons regulates cocaine addiction. J Exp Med (2010) 1.40
Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations. Neurobiol Dis (2009) 1.31
Altered sensitivity to rewarding and aversive drugs in mice with inducible disruption of cAMP response element-binding protein function within the nucleus accumbens. J Neurosci (2009) 1.30
Regulation of MiR-124, Let-7d, and MiR-181a in the accumbens affects the expression, extinction, and reinstatement of cocaine-induced conditioned place preference. Neuropsychopharmacology (2011) 1.29
Induction of nuclear factor-kappaB in nucleus accumbens by chronic cocaine administration. J Neurochem (2001) 1.29
Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome--Mecp2 gene dosage effects and BDNF expression. Eur J Neurosci (2008) 1.29
TORC1 regulates activity-dependent CREB-target gene transcription and dendritic growth of developing cortical neurons. J Neurosci (2009) 1.28
A psychodynamic study of a patient during experimental self-regulated re-addiction to morphine. Psychiatr Q (1952) 1.27
microRNA-Seq reveals cocaine-regulated expression of striatal microRNAs. RNA (2011) 1.26
Different lengths of times for progressions in adolescent substance involvement. Addict Behav (2006) 1.26
Cocaine self-administration "binges": transition from behavioral and autonomic regulation toward homeostatic dysregulation in rats. Psychopharmacology (Berl) (2000) 1.26
Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling. J Chem Neuroanat (2006) 1.25
Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci (2010) 5.98
Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med (2008) 5.62
Habenular α5 nicotinic receptor subunit signalling controls nicotine intake. Nature (2011) 3.77
Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A (2005) 3.05
MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci (2010) 3.00
Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev (2004) 2.97
Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat Neurosci (2002) 2.83
Striatal microRNA controls cocaine intake through CREB signalling. Nature (2010) 2.56
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci U S A (2009) 2.00
Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci U S A (2008) 1.94
MicroRNAs in neuronal function and dysfunction. Trends Neurosci (2012) 1.94
MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci U S A (2012) 1.49
Argonaute 2 in dopamine 2 receptor-expressing neurons regulates cocaine addiction. J Exp Med (2010) 1.40
Molecular mechanisms underlying behaviors related to nicotine addiction. Cold Spring Harb Perspect Med (2013) 1.28
Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice. Behav Pharmacol (2008) 1.23
Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability. Neuropharmacology (2013) 1.18
Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. Biochem Pharmacol (2011) 1.17
Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. Proc Natl Acad Sci U S A (2014) 1.08
Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories. Neurotox Res (2002) 1.06
Decreased brain reward function during nicotine withdrawal in C57BL6 mice: evidence from intracranial self-stimulation (ICSS) studies. Pharmacol Biochem Behav (2008) 1.04
Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice. J Neurosci (2012) 1.02
Intravenous nicotine self-administration and cue-induced reinstatement in mice: effects of nicotine dose, rate of drug infusion and prior instrumental training. Neuropharmacology (2011) 0.98
Orexin-1 receptor mediation of cocaine seeking in male and female rats. J Pharmacol Exp Ther (2011) 0.96
Role of α5* nicotinic acetylcholine receptors in the effects of acute and chronic nicotine treatment on brain reward function in mice. Psychopharmacology (Berl) (2013) 0.91
Rational development of addiction pharmacotherapies: successes, failures, and prospects. Cold Spring Harb Perspect Med (2012) 0.89
Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions. Nicotine Tob Res (2012) 0.88
MeCP2 phosphorylation limits psychostimulant-induced behavioral and neuronal plasticity. J Neurosci (2014) 0.88
Hypocretin-1 receptors regulate the reinforcing and reward-enhancing effects of cocaine: pharmacological and behavioral genetics evidence. Front Behav Neurosci (2012) 0.88
Patterns of responding differentiate intravenous nicotine self-administration from responding for a visual stimulus in C57BL/6J mice. Psychopharmacology (Berl) (2010) 0.86
Targeted deletion of the mouse α2 nicotinic acetylcholine receptor subunit gene (Chrna2) potentiates nicotine-modulated behaviors. J Neurosci (2013) 0.86
Habenular signaling in nicotine reinforcement. Neuropsychopharmacology (2012) 0.86
Prolonged nicotine exposure does not alter GABA(B) receptor-mediated regulation of brain reward function. Neuropharmacology (2005) 0.85
MicroRNAs and Drug Addiction. Front Genet (2013) 0.80
Methylation, memory and addiction. Epigenetics (2011) 0.79
Cracking the molecular code of cocaine addiction. ILAR J (2011) 0.79
Utility of genetically modified mice for understanding the neurobiology of substance use disorders. Hum Genet (2011) 0.79
Disubstituted piperidines as potent orexin (hypocretin) receptor antagonists. Bioorg Med Chem Lett (2012) 0.78
'Macrophage' cannabinoid receptor goes up in smoke. Nat Neurosci (2011) 0.77
The triple reuptake inhibitor DOV 216,303 induces long-lasting enhancement of brain reward activity as measured by intracranial self-stimulation in rats. Eur J Pharmacol (2012) 0.77
How can we begin to measure recovery? Subst Abuse Treat Prev Policy (2010) 0.75
Exploring the epigenetics of cocaine resistance. Nat Med (2013) 0.75